BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10392967)

  • 1. A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis.
    Abán JL; Ramajo V; Arellano JL; Oleaga A; Hillyer GV; Muro A
    Vet Parasitol; 1999 Jun; 83(2):107-21. PubMed ID: 10392967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of mice against schistosoma bovis with a recombinant fatty acid binding protein from Fasciola hepatica.
    Abáné JL; Oleaga A; Ramajo V; Casanueva P; Arellano JL; Hillyer GV; Muro A
    Vet Parasitol; 2000 Jul; 91(1-2):33-42. PubMed ID: 10889358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combination of the aliphatic diamine AA0029 in ADAD vaccination system with a recombinant fatty acid binding protein could be a good alternative for the animal schistosomiasis control.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Ramajo-Martín V; Muro A
    Exp Parasitol; 2015 Jul; 154():134-42. PubMed ID: 25936981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Fasciola hepatica-derived fatty acid binding protein induces protection against schistosomiasis caused by Schistosoma bovis using the adjuvant adaptation (ADAD) vaccination system.
    Vicente B; López-Abán J; Rojas-Caraballo J; Pérez del Villar L; Hillyer GV; Martínez-Fernández AR; Muro A
    Exp Parasitol; 2014 Oct; 145():145-51. PubMed ID: 25124941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of purified 12 kDa and recombinant 15 kDa Fasciola hepatica antigens related to a Schistosoma mansoni fatty acid binding protein.
    Hillyer GV
    Mem Inst Oswaldo Cruz; 1995; 90(2):249-53. PubMed ID: 8531666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naltrexone; as an efficient adjuvant in induction of Th1 immunity and protection against Fasciola hepatica infection.
    Azizi H; Mirzaeei H; Nasiri AA; Bazi A; Mirzapour A; Khatami M; Nahavandi KH; Azimi A; Yaghoobi H
    Exp Parasitol; 2018 Jun; 189():66-71. PubMed ID: 29729492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
    Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
    Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and immunological characterization of fatty acid binding protein isoforms from Fasciola hepatica.
    Espino AM; Rodríguez Medina JR; Hillyer GV
    J Parasitol; 2001 Oct; 87(5):1028-33. PubMed ID: 11695360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein.
    Rodríguez-Pérez J; Rodríguez-Medina JR; García-Blanco MA; Hillyer GV
    Exp Parasitol; 1992 Jun; 74(4):400-7. PubMed ID: 1592092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Schistosoma bovis Sb14-3-3zeta recombinant protein cross-protects against Schistosoma mansoni in BALB/c mice.
    Siles-Lucas M; Uribe N; López-Abán J; Vicente B; Orfao A; Nogal-Ruiz JJ; Feliciano AS; Muro A
    Vaccine; 2007 Oct; 25(41):7217-23. PubMed ID: 17707955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: host responders and nonresponders to parasite glutathione S-transferase.
    Hillyer GV; Soler de Galanes M; Battisti G
    Exp Parasitol; 1992 Sep; 75(2):176-86. PubMed ID: 1516666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response and antigenemia in sheep experimentally infected with Schistosoma bovis. Cross-reactivity with Fasciola hepatica antigens.
    Rodriguez-Osorio M; Gómez-García V; Rojas J; Ramajo-Martin V
    J Parasitol; 1999 Jun; 85(3):585-7. PubMed ID: 10386463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
    Tendler M; Vilar MM; Brito CA; Freire NM; Katz N; Simpson A
    Mem Inst Oswaldo Cruz; 1995; 90(2):255-6. PubMed ID: 8531667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprophylaxis against Fasciola hepatica in rabbits using a recombinant Fh15 fatty acid-binding protein.
    Casanueva R; Hillyer GV; Ramajo V; Oleaga A; Espinoza EY; Muro A
    J Parasitol; 2001 Jun; 87(3):697-700. PubMed ID: 11426738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egg-hatching inhibition in mice immunized with recombinant Schistosoma bovis 28 kDa glutathione S-transferase.
    Da Costa AV; Gaubert S; Lafitte S; Fontaine J; Capron A; Grzych JM
    Parasite Immunol; 1999 Jul; 21(7):341-50. PubMed ID: 10417668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antigens of Paragonimus westermani, Schistosoma mansoni, and Fasciola hepatica adult worms. Evidence for the presence of cross-reactive antigens and for cross-protection to Schistosoma mansoni infection using antigens of Paragonimus westermani.
    Hillyer GV; Serrano AE
    Am J Trop Med Hyg; 1983 Mar; 32(2):350-8. PubMed ID: 6404188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola: kinetics and quality of humoral responses to fatty acid binding protein and cathepsin l following delivery as DNA vaccines in mice.
    Smooker PM; Kennedy NJ; Steeper KR; Christopoulos H; Spithill TW
    Exp Parasitol; 2001 Mar; 97(3):154-60. PubMed ID: 11312577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.